Composition for preventing or treating cervical cancer including gypenoside LXXV

Abstract

Provided are a pharmaceutical composition for preventing or treating cervical cancer including gypenoside LXXV or a pharmaceutically acceptable salt thereof as an active ingredient, a method of preventing or treating cervical cancer including administering the pharmaceutical composition to a subject excluding humans, a health functional food composition for preventing or improving cervical cancer including gypenoside LXXV as an active ingredient, and a feed composition for preventing or improving cervical cancer including gypenoside LXXV as an active ingredient.

What is claimed is: 
     
       1. A method for preventing or treating cervical cancer, comprising a step of administering a pharmaceutical composition comprising gypenoside LXXV represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient: 
       
         
           
           
               
               
           
         
       
     
     
       2. The method of  claim 1 , wherein the gypenoside LXXV is obtained from ginsenoside Rb1 by deglycosylation. 
     
     
       3. The method of  claim 1 , wherein the composition further comprises a pharmaceutically acceptable carrier, excipient, or diluent. 
     
     
       4. A method for improving cervical cancer, comprising a step of administering a pharmaceutically effective amount of gypenoside LXXV represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof: 
       
         
           
           
               
               
           
         
       
     
     
       5. The method of  claim 4 , wherein the gypenoside LXXV is obtained from ginsenoside Rb1 by deglycosylation.